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ABSTRACT 
Lung cancer remains one of the deadliest types of cancer, causing approximately 160,000 
deaths per year in the US alone. Because of its poor detection techniques and highly invasive 
abilities, conventional treatments -such as radiation and chemotherapy- fail to improve long-term 
survival of patients. At the moment, the 5-year survival rate for all stages of lung cancer is only 
16%. Recent breakthroughs in cancer research establish immunotherapy, which involves the 
stimulation of the immune system to target and attack cancer cells, as a highly promising 
alternative treatment against this deadly disease. However, the efficiency of this treatment varies 
on each subset of cancer. A more efficient therapeutic strategy should include the targeting of 
immunosuppressive factors along with key proteins that are responsible for lung tumor growth. 
A possible target is the Retinoblastoma protein (Rb). This well-known tumor suppressor 
regulates a diverse set of cellular processes such as cell cycle progression and cell adhesion. 
Inactivation of Rb results in uncontrolled cell proliferation, which is a major driving force behind 
tumorigenesis. Recent findings suggest a new role for Rb in regulating immune system function. 
To further characterize this emerging role of Rb in immune function, the protein expression of 
PD-L1, PD1, OX-40, OX40L, B7-H3 and B7-H4 was analyzed via immunoblotting in Rb-
activated and Rb-inactivated lung cancer cell lines. Our hypothesis is that Rb will affect the 
expression of these immunosuppressive factors in tumor cells. Preliminary results show that PD-
L1 and OX-40 expression is correlated to Rb active status, while PD1 and OX40L are expressed 
when Rb is inactivated.  
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